Roivant Sciences Ltd. (87S.F)
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
29.76+0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+213.4%
The outlook
Roivant Sciences Ltd. currently reads as bullish based on above its 50- & 200-day averages, 89% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range89% of the way from its 52-week low to high
Market cap
$21.50B
52-wk high
32.21
52-wk low
9.11
50-day avg
28.00
200-day avg
22.58
Trailing P/E
—